Telum Therapeutics
PrivateLast Round
Series A
Jul 1, 2026
Total Funding Raised
$25.65M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Telum Therapeutics is a biotechnology company that develops antimicrobial therapies based on engineered phage lytic proteins to treat multidrug-resistant bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Telum Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Telum Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 1, 2026 | ||||
| Seed | Jul 13, 2020 |
Key People
Founding team and executive leadership
Telum Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AMR Action Fund | Series A |
| CDTI Innvierte | Series A, Seed |
| Inveready | Series A |
| Clave Capital | Series A, Seed |
| Center for Technological Development and Innovation | Series A |
| Invivo Partners | Series A, Seed |
| Sodena | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
$21M round led by AMR Action Fund.
- Jun 23, 2026
Monthly visitors increased 82% MoM.
Telum Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Telum Therapeutics's valuation, stock price, and market status.